TG Therapeutics Correlations

TGTX Stock

USD 29.55 0.41 1.41%

The current 90-days correlation between TG Therapeutics and Madrigal Pharmaceuticals is 0.17 (i.e., Average diversification). The correlation of TG Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

TG Therapeutics Correlation With Market

Average diversification

The correlation between TG Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TG Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy TGTX Stock please use our How to Invest in TG Therapeutics guide.

Moving together with TGTX Stock

0.86	VCEL	Vericel Corp Ord	Pair Corr
0.81	VCYT	Veracyte Potential Growth	Pair Corr
0.82	DVAX	Dynavax Technologies	Pair Corr
0.68	DYAI	Dyadic International	Pair Corr
0.83	VTRS	Viatris	Pair Corr

Moving against TGTX Stock

0.88	VALN	Valneva SE ADR	Pair Corr
0.8	ME	23Andme Holding	Pair Corr
0.72	DRRX	Durect	Pair Corr
0.7	EQ	Equillium	Pair Corr
0.65	VINC	Vincerx Pharma	Pair Corr
0.62	VIGL	Vigil Neuroscience	Pair Corr
0.62	VIRX	Viracta Therapeutics	Pair Corr
0.61	DRMA	Dermata Therapeutics	Pair Corr
0.6	DNTH	Dianthus Therapeutics	Pair Corr
0.56	DTIL	Precision BioSciences	Pair Corr
0.33	DNLI	Denali Therapeutics	Pair Corr
0.31	DOMH	Dominari Holdings	Pair Corr
0.79	VXRT	Vaxart Inc	Pair Corr
0.75	EDSA	Edesa Biotech	Pair Corr
0.68	VTGN	VistaGen Therapeutics	Pair Corr
0.58	VKTX	Viking Therapeutics	Pair Corr
0.56	EDIT	Editas Medicine	Pair Corr
0.55	VRCA	Verrica Pharmaceuticals	Pair Corr
0.52	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.52	VRPX	Virpax Pharmaceuticals	Pair Corr
0.48	VYGR	Voyager Therapeutics	Pair Corr

Related Correlations Analysis

	MDGL	ICPT	TERN	HEPA	EXEL	VKTX	BTAI	AKRO	RETA	XFOR
MDGL		-0.64	-0.33	-0.24	0.87	-0.44	-0.24	0.17	-0.29	0.07	MDGL
ICPT	-0.64		0.75	0.42	-0.73	0.81	0.63	0.4	-0.03	0.02	ICPT
TERN	-0.33	0.75		0.57	-0.46	0.8	0.63	0.74	-0.49	0.0	TERN
HEPA	-0.24	0.42	0.57		-0.32	0.7	0.68	0.61	-0.46	-0.47	HEPA
EXEL	0.87	-0.73	-0.46	-0.32		-0.55	-0.35	-0.05	-0.19	-0.07	EXEL
VKTX	-0.44	0.81	0.8	0.7	-0.55		0.86	0.68	-0.34	-0.24	VKTX
BTAI	-0.24	0.63	0.63	0.68	-0.35	0.86		0.62	-0.43	-0.22	BTAI
AKRO	0.17	0.4	0.74	0.61	-0.05	0.68	0.62		-0.68	-0.18	AKRO
RETA	-0.29	-0.03	-0.49	-0.46	-0.19	-0.34	-0.43	-0.68		0.3	RETA
XFOR	0.07	0.02	0.0	-0.47	-0.07	-0.24	-0.22	-0.18	0.3		XFOR
	MDGL	ICPT	TERN	HEPA	EXEL	VKTX	BTAI	AKRO	RETA	XFOR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

EXEL	+ 0.87	MDGL
BTAI	+ 0.86	VKTX
VKTX	+ 0.81	ICPT
VKTX	+ 0.8	TERN
TERN	+ 0.75	ICPT
AKRO	+ 0.74	TERN

High negative correlations

EXEL	- 0.73	ICPT
RETA	- 0.68	AKRO
ICPT	- 0.64	MDGL
VKTX	- 0.55	EXEL
RETA	- 0.49	TERN
XFOR	- 0.47	HEPA

Risk-Adjusted Indicators

There is a big difference between TGTX Stock performing well and TG Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze TG Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MDGL	2.90	0.56	0.16	0.80	3.01	(3.33)	5.53	(4.66)	33.61
ICPT	2.96	(0.80)	0.00	(0.98)	0.00	0.00	5.23	(8.32)	38.17
TERN	3.09	(0.76)	0.00	(1.08)	0.00	0.00	5.17	(6.80)	26.61
HEPA	4.89	(0.08)	0.00	(0.22)	0.00	0.00	9.33	(8.54)	41.03
EXEL	1.64	0.50	0.32	1.97	1.18	(1.97)	4.41	(2.27)	16.74
VKTX	3.33	(0.95)	0.00	(1.11)	0.00	0.00	4.89	(9.14)	39.28
BTAI	5.54	(0.40)	0.00	17.91	0.00	0.00	9.62	(11.11)	56.57
AKRO	2.70	(0.23)	0.00	(0.66)	0.00	0.00	5.23	(5.05)	16.66
RETA	2.22	0.21	0.05	(0.27)	3.31	(2.35)	5.24	(3.51)	28.80
XFOR	7.61	0.76	0.05	(0.55)	10.73	(10.40)	26.42	(13.51)	67.48

TG Therapeutics Corporate Executives

Elected by the shareholders, the TG Therapeutics' board of directors comprises two types of representatives: TG Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TGTX. The board's role is to monitor TG Therapeutics' management team and ensure that shareholders' interests are well served. TG Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TG Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Sean CPA

Corporate CFO

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC